Sangamo Therapeutics Inc (NASDAQ: SGMO) is -35.71% lower on its value in year-to-date trading and has touched a low of $0.30 and a high of $3.18 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SGMO stock was last observed hovering at around $0.82 in the last trading session, with the day’s loss setting it -0.16%.
Currently trading at $0.66, the stock is -27.03% and -36.55% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 13.51 million and changing -20.02% at the moment leaves the stock -43.68% off its SMA200. SGMO registered 4.98% gain for a year compared to 6-month gain of -22.34%. The firm has a 50-day simple moving average (SMA 50) of $1.034 and a 200-day simple moving average (SMA200) of $1.1647.
The stock witnessed a -35.71% loss in the last 1 month and extending the period to 3 months gives it a -75.06%, and is -24.62% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 9.50% over the week and 11.02% over the month.
Sangamo Therapeutics Inc (SGMO) has around 183 employees, a market worth around $147.36M and $57.80M in sales. Profit margin for the company is -171.67%. Distance from 52-week low is 115.72% and -79.37% from its 52-week high. The company has generated returns on investments over the last 12 months (-202.41%).
with sales reaching $5.3M over the same period.The EPS is expected to grow by 48.40% this year, but quarterly earnings will post 19.28% year-over-year. Quarterly sales are estimated to grow 1,001.87% in year-over-year returns.
Sangamo Therapeutics Inc (SGMO) Top Institutional Holders
149.0 institutions hold shares in Sangamo Therapeutics Inc (SGMO), with institutional investors hold 28.09% of the company’s shares. The shares outstanding are 224.71M, and float is at 214.59M with Short Float at 13.47%. Institutions hold 27.48% of the Float.
The top institutional shareholder in the company is WASATCH ADVISORS LP with over 20.09 million shares valued at $7.2 million. The investor’s holdings represent 9.8509% of the SGMO Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 14.06 million shares valued at $5.04 million to account for 6.894 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 11.9 million shares representing 6.5977% and valued at over $4.26 million, while BLACKROCK INC. holds 2.306 of the shares totaling 4.7 million with a market value of $1.69 million.
Sangamo Therapeutics Inc (SGMO) Insider Activity
#####
